News GSK’s Relvar Ellipta comes out on top in real world study Encouraging results will support growth of its next generation respiratory treatment
News Circassia gives up on allergy treatments after second trial ... UK biotech to focus on respiratory drugs after house dust mite therapy fails.
News AZ strikes COPD deal with Circassia, suffers setback with bl... FDA rejects blood potassium drug for second time.
News Good news for GSK’s next generation asthma drug Results mean patients could switch to once-daily inhaler use
News Propeller Health to bring smart inhaler tech to Novartis' Br... Partnership will focus on COPD in Europe.
News Stop obsessing about generic Advair, says GSK's Witty Growth elsewhere will soak up impact of US competitor, says Sir Andrew Witty.
R&D The long-delayed promise of the microbiome, with Sam Possemi... Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
